课题基金 / 基金详情

项目摘要

项目成果

KUMAR SUBRAMANIAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant) Phoenix Biosystem intends to leverage the in-house expertise in sensors, microfluidics, and microelectronics to design, develop and validate novel, battery powered portable measurement technologies which, by the end of the Phase II funding period, will result in field-deployable tools that would provide accurate internal assessment of internal dose and/or activity of priority environmental exposures in real time. The sensors would have the ability to measure multiple agents within a single class of exposure i.e. pesticides. The Phase I prototype will detect personal exposure to OP conjugates in whole blood samples. Since the resultant OP conjugate typically correlates directly with the OP structure, an antibody-based nanoarray analysis would be superior to the current, end point-based colorimetric method.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
RAPID POINT OF CARE DIAGNOSTICS FOR HCV
  • 批准号:
    10497110
  • 项目类别:
  • 资助金额:
    $30.0万
  • 财政年份:
    2021
  • 负责人:
    KUMAR SUBRAMANIAN
  • 依托单位:
Low cost, automated smartphone based assay for semen analysis
  • 批准号:
    10028296
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2020
  • 负责人:
    KUMAR SUBRAMANIAN
  • 依托单位:
Multiplexed Point Of Care Nucleic Acid Assay for STI
  • 批准号:
    9074908
  • 项目类别:
  • 资助金额:
    $19.79万
  • 财政年份:
    2016
  • 负责人:
    KUMAR SUBRAMANIAN
  • 依托单位:
IGF::OT::IGFTitle: Multiplexed Biosensor for Detecting Low Abundance Cancer-rel
  • 批准号:
    8761949
  • 项目类别:
  • 资助金额:
    $99.98万
  • 财政年份:
    2013
  • 负责人:
    KUMAR SUBRAMANIAN
  • 依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
  • 批准号:
    2022J011295
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2022
  • 负责人:
    王亚伟
  • 依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究